Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Cancer. 2021 Aug 3;127(21):3957–3966. doi: 10.1002/cncr.33679

Table 1:

Pooled participant specialties and practice information.

Specialty

Urology 13 (39%)

Medical oncology 12 (36%)

Genetic counselor 4 (12%)

Clinical geneticist 2 (6%)

Patient advocate 2 (6%)

Years in practice

Average 13.1 +/− 9.6

How many patients do you recommend for kidney cancer genetic risk assessment annually?

< 10 2 (6%)

10–20 6 (20%)

20–50 12 (40%)

> 50 6 (20%)

Do you order your own germline testing?

Yes 19 (63%)

No 7 (23%)

How often have your patients had trouble with insurance reimbursement for genetic testing?

0% 4 (13%)

0-20% 9 (30%)

20-50% 8 (27%)

> 50% 2 (7%)